Riboflavin and health: A review of recent human research

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 17, 2017, Pages 3650-3660

  Thakur, Kiran ^a   Tomar, Sudhir Kumar ^a   Singh, Ashish Kumar ^a   Mandal, Surajit ^a   Arora, Sumit ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

anemia; cataract; deficiency; diseases; oxidative stress; Riboflavin; risk

Indexed keywords

AMINO ACIDS; HEALTH; METABOLISM; OXIDATIVE STRESS; PHOTOSENSITIZERS; PHYSIOLOGY; RISKS; VIRUSES;

ANEMIA; CATARACT; DEFICIENCY; GASTROINTESTINAL TRACT; HEALTH IMPLICATIONS; INTESTINAL ABSORPTION; MITOCHONDRIAL DYSFUNCTION; RIBOFLAVIN;

DISEASES;

RIBOFLAVIN; VITAMIN;

CHRONIC DISEASE; DIABETES MELLITUS; DIET; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; METABOLISM; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RIBOFLAVIN DEFICIENCY;

CHRONIC DISEASE; DIABETES MELLITUS; DIET; HEALTH STATUS; HUMANS; HYPERGLYCEMIA; NUTRITIONAL REQUIREMENTS; OXIDATIVE STRESS; RIBOFLAVIN; RIBOFLAVIN DEFICIENCY; VITAMINS;

EID: 85020753940     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2016.1145104     Document Type: Article

References (136)

1. Alam, M. M., Iqbal, S., and Naseem, I., (2015). Ameliorative effect of riboflavin on hyperglycemia, oxidative stress and DNA damage in type-2 diabetic mice:mechanistic and therapeutic strategies. Archi. Biochem. Biophys. 584:10–19.
2. Ambrosio, G., Flaherty, J. T., and Duilio, C., (1991). Oxygen radicals generated at reflow induce peroxidation of membrane lipids in repurfused hearts. J. Clin. Invest. 87:2056–2066.
3. 2) and oxidative stress:a review. Br. J. Nutr. 20:1–7.
4. Bajwa, Z. H., and Sabahat, A., (2008). Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. Up To Date 2008. Available at www.uptodate.com.
5. Bamji, M. S., (1983). Vitamin deficiencies in rice-eating populations. Effects of B vitamin supplements. Experientia Suppl. 44:245–263.
6. Bareford, L. M., Phelps, M. A., and Foraker, A. B., (2005). Intracellular processing of riboflavin in human breast cancer cells. Mol. Pharm. 5:839–848.
7. Bates, C., (1993). Riboflavin. Int. J. Vitam. Nutr. Res. 63:274–277.
8. Bertollo, C. M., Oliveira, A. C., Rocha, L. T., Costa, K. A., Nascimento, E. B., and Coelho, M. M., (2006). Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur. J. Pharmacol. 547:184–191.
9. Beutler, E., (1969). Glutathione reductase; stimulation in normal subjects by riboflavin supplementation. Scieik. Tl. 165:613–615.
10. Bhat, K. S., (1987). Nutritional states of thiamine, riboflavin, and pyridoxine in cataract patients. Nutr. Rep. Int. 36:685–692.
11. Blanck, H. M., Bowman, B. A., Serdula, M. K., Khan, L. K., Kohn, W., and Woodruff, B. A., (2002). Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in Southeastern Nepal. Am. J. Clin. Nutr. 76:430–435.
12. Boisvert, W. A., Castaneda, C., Mendoza, I., Langeloh, G., Solomons, N. W., Gershoff, S. N., and Russell, R. M., (1993). Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intake. Am. J. Clin. Nutr. 58:85–90.
13. Bolli, R., Zughaib, M., and Li, X. Y., (1995). Recurrent ischemia in the canine heart causes recurrent nursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial “stunning”. J. Clin. Invest. 96:1066–1084.
14. Bosch, A. M., Abeling, N. G., Ijlst, L., Knoester, H., Van der Pol, W. L., Stroomer, A. E., Wanders, R. J., Visser, G., Wijburg, F. A., Duran, M., and Waterham, H. R., (2011). Brown–Vialetto–Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD:a new inborn error of metabolism with potential treatment. J. Inherit. Metab. Dis. 34:159–164.
15. Brady, P. S., Brady, L. J, and Parsons, M. J., (1979). Effects of riboflavin deficiency in baby pig. J. Nutr. 109:1615–1622.
16. Butler, B. F., and Topham, R. W., (1993). Comparison of changes in the uptake and mucosal processing of iron in riboflavin-deficient rats. Biochem. Mol. Biol. Int. 30:53–61.
17. Carden, D. L., and Granger, D. N., (2000). Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190:255–266.
18. Cardo, L. J., Rentas, F. J., Ketchum, L., Salata, J., Harman, R., Melvin, W., Weina, P. J., Mendez, J., Reddy, H., and Goodrich, R., (2006). Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang. 90:85–91.
19. Condo, M., Posar, A., Arbizzani, A., and Parmeggiani, A., (2009). Riboflavin prophylaxis in pediatric and adolescent migraine. J. Headache Pain. 10:361–5.
20. Corbett, A. J., Eckle, S. B., Birkinshaw, R. W., Liu, L., Patel, O., Mahony, J., Chen, Z., Reantragoon, R., et al. (2014). T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509:361–365.
21. Corbin, F., (2002). Pathogen inactivation of blood coponents:current status and introduction of an approach using riboflavin as a photosensitizer. Int. J. Hematol. 76:253–257.
22. Daniel, H., Binninger, E., and Rehner, G., (1983). Hydrolysis of FMN and FAD by alkaline phosphatase of the intestinal brush border membrane. Int. J. Vitam. Nutr. Res. 53:109–114.
23. Depeint, F., Bruce, W. R., Shangari, N., Mehta, R., and O'Brien, P. J., (2006). Mitochondrial function and toxicity:role of the B vitamin family on mitochondrial energy metabolism. Chem. Biol. Interact. 163:94–112.
24. Dringen, R., Gutterer, J. M., and Hirrlinger, J., (2000). Glutathion metabolism in brain. Eur. J. Biochem. 267:4912–4916.
25. 6 in young healthy women. Ann. Nutr. Meta. 52:29–36.
26. Fairweather-Tair, S. J., Powers, H. J., and Minski, M. J., (1992). Riboflavin deficiency and iron absorption in adult Gambian men. AMH. Nutr. Metah. 36:34–40.
27. Fishman, S. M., Christian, P., and West, K. P., (2003). The role of vitamins in the prevention and control of anaemia. Pub. Health Nutr. 3:125–150.
28. Flynn, A., Moreiras, O., Stehle, P., Fletcher, R. J., Muller, D. J., and Rolland, V., (2003). Vitamins and minerals:a model for safe addition to foods. Eur. J. Clin. Nutr. 42:118–130.
29. Foley, A., Manoj, P., Pandraud, M. A., Gonzalez, M. A., and Al-Odaib, A., (2014). Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 137:44–56.
30. 12, Pantothenic Acid, Biotin, Folate and Choline. National Academies Press, Washington DC, USA, pp. 87–122.
31. Foy, H., Kondi, A., and Verjee, Z. H., (1972). Relation of riboflavin deficiency to corticosteroid metabolism and red cell hypoplasia in baboons. J. Nutr. 102:571–582.
32. Gallagher, M. L., (2012). Intake:the nutrients and their metabolisms. In:Krause's Food & the Nutrition Care Process, 13 ed., pp. 32–128.
33. Glatzle, D., Korner, W. F., Christeller, S., and Wiss, O., (1970). Method for the detection of a biochemical riboflavin deficiency. Stimulation of NADPH2-dependent glutathione reductase from human erythrocytes by FAD in vitro. Investigations on the vitamin B2 status in healthy people and geriatric patients. Int. Z. Vitaminforsch. 40:166–183.
34. Green, P., Wiseman, M., Crow, Y. J., Houlden, H., Riphagen, S., Lin, J. P., Raymon, F. L., Childs, A. M., Sheridan, E., Edwards, S., and Josifova, D. J., (2010). Brown–Vialetto–Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in C20orf54. Am. J. Hum. Genet. 86:485–489.
35. Greene, H. L., Specker, B. L., Smith, R., Murrell, J., and Swift, L., (1990). Plasma riboflavin concentrations in infants fed human milk versus formula:comparison with values in rats made riboflavin deficient and human cord blood. J. Pediatr. 117:916–920.
36. Guenther, B. D., Sheppard, C. A., Tran, P., Rozen, R., Matthews, R. G., Ludwig, M. L., et al. (1999). The structure and properties of methylenetetrahydrofolatereductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nature S. Bio. 6:359–365.
37. Hassan, I., Chibber, S., Khan, A. A., and Naseem, I., (2012). Riboflavin ameliorates cisplatin induced toxicities under photoillumination. Plos One.7:e36273.
38. 2:a promising adjuvant in cisplatin based chemoradiotherapy by cellular redox management. Food Chem. Toxicol. 59:715–723.
39. Hayes, J. D., and McLellan, L. I., (1999). Glutathione and glutathione- dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Rad. Res. 31:273–300.
40. Horigan, G., McNulty, H., Ward, M., Strain, J., Purvis, J. S.,, J. M., et al. (2010). Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C–>T polymorphism in MTHFR. J. Hypertension. 28:478–486.
41. Horiuchi, S., Hirano, H., and Ono, S., (1984). Reduced and oxidized glutathione concentrations in the lenses of riboflavin deficient rats. J. Nutr. Sci. Vitamin. 30:401–403.
42. Huang, J., Tian, L., and Wu, X., (2010). Effects of dietary riboflavin levels on antioxidant defence of the juvenile grouper Epinephelus coioides. Fish Physiol. Biochem. 36:55–62.
43. Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., and Ueland, P. M., (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin. Chem. 48:1571–1577.
44. Hustad, S., Ueland, P. M., Vollset, S. E., Zhang, Y., Bjørke-Monsen, A. L., and Schneede, J., (2000). Riboflavin as a determinant of plasma total homocysteine:effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin. Chem. 46:1065–1071.
45. Iinuma, S., (1995). Synthesis of riboflavin by intestinal bacteria. J. Vitam. 2:6–13.
46. Iwanaga, K., Hasegawa, T., and Hultquist, D. E., (2007). Riboflavin –mediated reduction of oxidant injury, rejection, vasculopathy after cardiac allotransplantation. Transplantation. 83:747–753.
47. Jayashree, S., Jayaraman, K., and Kalaichelvan, G., (2010). Isolation, screening and characterization of riboflavin producing lactic acid bacteria from katpadi, Vellore district. Recent Res. Sci. Technol. 2:83–88.
48. Koser, S. A., (1968). Vitamin Requirements of Bacteria and Yeasts. Charles C. Thomas, Springfield, IL.
49. Kukielka, G. L., Smith, C. W., and Manning, A. M., (1995.) Induction of interleukin-6 synthesis in the myocardium. Potential role in postrepurfusion inflammatory injury. Circulation. 92:1866–1875.
50. Kumar, V., Lockerbie, O., Keil, S. D., Ruane, P. H., Platz, M. S., Martin, C. B., Ravanat, J., Cadet, J., and Goodrich, R. P., (2004). Riboflavin and UV-light based pathogen reduction:extent and consequence of DNA damage at the molecular level. Photochem. Photobiol. 80:15–21.
51. Lakshmi, R., Lakshmi, A. V., Divan, P. V., and Bamji, M. S., (1991). Effect of riboflavin or pyridoxine deficiency on inflammatory response. Indian J. Biochem. Biophys. 28:481–484.
52. Lawes, C. M., Vander Hoorn, S., and Rodgers, A., (2008). International Society of Hypertension. Global burden of blood-pressure-related disease. Lancet. 371:1513–1518.
53. LeBlanc, J. G., Burgess, C., Sesma, F., de Giori, G. S., and van Sinderen, D., (2005). Lactococcus lactis is capable of improving the riboflavin status in deficient rats. Br. J. Nutr. 94:262–267.
54. LeBlanc, J. G., Laiño, J. E., del Valle, M. J., Vannini, V., van Sinderen, D., Taranto, M. P., de Valdez, G. F., de Giori, G. S., and Sesma, F., (2011). B group vitamin production by lactic acid bacteria—current knowledge and potential applications. J. Appl. Microbiol. 111:1297–1309.
55. LeBlanc, J. G., Milani, C., de Giori1, G. S., Sesma, F., van Sinderen, D, and Ventura, M., (2012). Bacteria as vitamin suppliers to their host:a gut microbiota perspective. Curr. Opin. Biotechnol. https://doi.org/10.1016/j.copbio.2012.08.005.
56. LeBlanc, J. G., Rutten, G., Bruinenberg, P., Sesma, F., de Giori, G. S., and Smid, E. J., (2006). A novel product fermented with Propionibacterium freudenreichii improves the riboflavin status of deficient rats. Nutrition. 22:645–651.
57. Leske, M. C., Wu, S. Y., and Hyman, L., (1995). Biochemical factors in the lens opacities. Case-control study. The lens opacities case-control study group. Arch. Ophthalmol. 113:1113–1119.
58. Levin, G., Cogan, U., and Levy, Y., (1990). Riboflavin deficiency and the function and fluidity of rat erythrocyte membranes. J. Nutr. 120:857–861.
59. Levy, D., Ehret, G. B., Rice, K., Verwoert, G. C., Launer, L. J., Dehghan, A, et al. (2009). Genome-wide association study of blood pressure and hypertension. Nature Genet. 41:677–687.
60. Li, N., Peng, X. J., Fan, Z. J., Pang, X., Xia, Y., and Wu, T. F., (2015). Riboflavin concentration in corneal stroma after intracameral injection. Int. J. Opthalmol. 8:470–475.
61. Liu, T., Soong, S. J., Wilson, N. P., Craig, C. B., Cole, P., Macaluso, M., and Butterworth, C. E., (1993). A case control study of nutritional factors and cervical dysplasia. Cancer Epidemiol. Biomarkers Prev. 2:525–530.
62. Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., and Murray, C. J., (2006). Global and regional burden of disease and risk factors, 2001:systematic analysis of population health data. Lancet. 367:1747–1757.
63. Maizels, M., Blumenfeld, A., and Burchette, R., (2004). A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis:a randomized trial. Headache. 44:885–90.
64. Mamede, A. C., Tavares, S. D., Abrantes, A. M., Trindade, J., Maia, J. M., and Botelho, M. F., (2011). The role of vitamins in cancer:a review. Nutr. Cancer. 63:479–494.
65. Mazur-Bialy, A. I., Buchala, B., and Plytycz, B., (2013). Riboflavin deprivation inhibits macrophage viability and activity—a study on the RAW 264.7 cell line. Br. J. Nutr. 110:509–514.
66. McCormic, D. B., (2003). Metabolism of vitamins in microbes and mammals. Biochem. Biophys. Res. Commun. 312:97–101.
67. McNulty, H., Dowey le, R. C., Strain, J. J., Dunne, A., Ward, M., Molloy, A. M., et al. (2006). Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation. 113:74–80.
68. Mensink, G. B., Fletcher, R., Gurinovic, M., Huybrechts, I., Lafay, L., Serra- Majem, L., Szponar, L., Tetens, I., Verkaik-Kloosterman, J., Baka, A., and Stephen, A. M., (2013). Mapping low intake of micronutrients across Europe. Br. J. Nutr. 110:755–773.
69. Nakano, E., Mushtaq, S., Heath, P. R., Lee, S., Bury, J. P., Riley, S. A., et al. (2011). Riboflavin depletion impairs cell proliferation in adult human duodenum:identification of potential effectors. Dig. Dis. Sci. 56:1007–10019.
70. Naseem, I., Hassan, I., Alhazza, I. M., and Chibber, S., (2015). Protective effect of riboflavin on cisplatin induced toxicities:A gender-dependent study. J. Trace Elem. Med. Biol. 29:303–314.
71. Newton-Cheh, C., Johnson, T., and Gateva, V., (2009). Global BPgen consortium. Genome-wide association study identifies eight loci associated with blood pressure. Nature Genet. 41:666–676.
72. O'Brien, M. M., Kiely, M., Harrington, K. E., Robson, P. J., Strain, J. J., and Flynn, A., (2001). The North/South ireland food consumption survey:vitamin intakes in 18–64-year-old adults. Pub. Health Nutr. 4:1069–1079.
73. Ogunleye, A. J., and Odutuga, A. A., (1989). The effect of riboflavin deficiency on cerebrum and cerebellum of developing rat brain. J. Nutr. Sci. Vitaminol. 35:193–197.
74. Ono, S., Hirano, H., Kudo, L., and Obara, K., (1976). Some biochemical changes in lenses of riboflavin defeicient rats. Int. J. Vit. Nutr. Res. 46:422–426.
75. Pangrekar, J., Krishnaswamy, K., and Jagadeesan, V., (1993). Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. Food Chem. Toxicol. 31:745–750.
76. Pangrekar, J., Krishnaswamy, K., and Jagadeesan, V., (1993). Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. Food Chem. Toxicol. 31:745–750.
77. Pelletier, J. P., Transue, S., and Snyder, E. L., (2006). Pathogen inactivation techniques. Best Pract. Res. Clin. Haematol. 19:205–242.
78. Pompella, A., Visvikis, A., and Paolicchi, A., (1982). The changing faces of glutathione reductase. J. Mol. Biol. 160:287–308.
79. Powers, H. J., (1997). A study of maternofetal iron transfer in the riboflavin deficient rat. J. Nutr. 117:852–856.
80. Powers, H. J., (2003). Riboflavin (vitamin B-2) and health. Am. J. Clin. Nutr. 77:1352–1360.
81. Powers, H. J., (2005). Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. International Conference on Diet, Nutrition, and Cancer. 0022-3166/05 American Society for Nutrition.
82. Powers, H. J., Bates, C. J., Prentice, A. M., Lamb, W. H., and Jepson, M., (1983) The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anemia in men and children in rural gambia. Hum. Nutr. Clin. Nutr. 37:413–425.
83. Powers, H. J., Hill, M. H., Mushtaq, S., Dainty, J. R., and Majsak-Newman, G., (2011). Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM). Am. J. Clin. Nutr. 93:1274–1284.
84. Powers, H. J., Weaver, L. T., Austin, S., and Beresford, J. K., (1993). A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat. Br. J. Nutr. 69:553–561.
85. Powers, H. J., Weaver, L. T., Austin, S., and Wright, A. J., (1991). Fairweather-Tait, S.J.Riboflavin deficiency in the rat:effects on iron utilization and loss. Br. J. Nutr. 65:487–496.
86. Powers, H. J., Weaver, L. T., Austin, S., Wright, A. J., and Fairweather-Tait, S. J., (1991). Riboflavin deficiency in the rat:effects on iron utilization and loss. Br. J. Nutr. 65:487–496.
87. Powers, H. J., Wright, A. J., and Fairweather-Tait, S. J., (1988). The effect of riboflavin deficiency in rats on the absorption and distribution of iron. Br. J. Nutr. 59:381–387.
88. Rao, P. N., Levine, E., Myers, M. O., Prakash, V., and Watson, J., (1999). Elevation of serum riboflavin carrier protein in breast cancer. Cancer Epidemiol. Biomarkers Prev. 8:985–990.
89. Rivilin, R. S., (2010). Riboflavin. Encyclopedia of Dietary supplements, pp. 691–699. Coates, P. M., Betz, J. M., Blackman, M. R., et al. Informa healthcare, London and New York.
90. Rivlin, R. S., (1973). Riboflavin and cancer:a review. Cancer Res. 33.
91. Roughead, Z. K., and McCormick, D. B., (1991). Urinary riboflavin and its metabolites:effects of riboflavin supplementation in healthy residents of rural Georgia (USA). Eur. J. Clin. Nutr., 45:299–307.
92. Ruane, P. H., Edrich, R., Gampp, D., Keil, S. D., Leonard, R. L., and Goodrich, R. P., (2004). Photochemical inactivation of selected viruses and bacteria platelet concentrates using riboflavin and light. Transfusion. 44:877–885.
93. Russo, P., Capozzi, V., Arena, M. P, Spadaccino, G., Duenas, M. T., Lopez, P., Fiocco, D., and Spano, G., (2014). Riboflavin-overproducing strains of Lactobacillus fermentum for riboflavin-enriched bread. Appl. Microbiol. Biotechnol. 98:3691–3700.
94. Said, H. M., (2011). Intestinal absorption of water-soluble vitamins in health and disease. Biochem. J. 437:357–372.
95. Said, H. M., (2011). Intestinal absorption of water-soluble vitamins in health and disease. Biochem. J. 437:357–372.
96. Said, H. M., and Khani, R., (1993). Uptake of riboflavin across the brush border membrane of rat intestine:regulation by dietary vitamin levels. Gastroenterol. 105:1294–1298.
97. Said, H. M., and Ma, T. Y., (1994). Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells. Am. J. Physiol. 266:15–21.
98. Said, H. M., and Mohammadkhani, R., (1993). Uptake of riboflavin across the brush border membrane of rat intestine:regulation by dietary vitamin levels. Gastroenterol. 105:1294–1298.
99. Said, H. M., Ortiz, A., Moyer, M. P., and Yanagawa, N., (2000). Riboflavine uptake by human-derived colonic epithelial NCM460 cells. Am. J. Physiol. 278:270–276.
100. Said, H. M., and Ross, C., (2011). Riboflavin. Modern Nutrition Health Disease 11:325–330.
101. Said, H. M., and Trebble, T., (2015). Intestinal digestion and absorption of micronutrients. In:Slesenger and Fordtran GI and Liver Disease, 10th edn., pp. 1765–88. Feldman, M., Friedman, L., and Brandt L., Eds., Elsevier.
102. Sakurai, H., Kawabata, K., Sakurai, F., Nakagawa, S., and Mizuguchi, H., (2007). Innate immune response induced by gene delivery vectors. Int. J. Pharm. doi:10.1016/j.ijpharm.06.012.
103. Sandor, P. S., Afra, J., Ambrosini, A., and Schoenen, J., (2000). Prophylactic treatment of migraine with betablockers and riboflavin:differential effects on the intensity dependence of auditory evoked cortical potentials. Headache. 40:30–33.
104. Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., and Magis, D., (2005). Efficacy of coenzyme Q10 in migraine prophylaxis:a randomized controlled trial. Neurology. 64:713–715.
105. Schoenen, J., Jacquy, J., and Lenaerts, M., (1998). Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 50:466–470.
106. Schramm, M., Wiegmann, K., Schramm, S., Gluschko, A., Herb, M., Utermohlen, O., et al. (2014). Riboflavin (vitamin B2) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes. Eur. J. Immunol. 44:728–41.
107. Sherwood, M. D., Ran, D., and Goldman, M. D., (2014). Effectiveness of riboflavin in pediatric migraine prevention. Can. Fam. Physician Mars. 60:157–159.
108. Shi, Z., Zhen, S., Wittert, G. A., Yuan, B., Zuo, H., and Taylor, A. W., (2014). Inadequate riboflavin intake and anemia risk in a Chinese population:five-year follow up of the jiangsu nutrition study. PLoS ONE 9:e88862. doi:10.1371/journal.pone.0088862.
109. Siassi, F., Pouransari, Z., and Ghadirian, P., (2000). Nutrient intake and esophageal cancer in the Caspian littoral of Iran:a case-control study. Cancer Detect. Prev. 24:295–303.
110. Skalka, H. W., and Prchal, J. T., (1981). Cataracts and riboflavin deficiency. Am. J. Clin. Nutr. 34:861–863.
111. Sparaco, M., Feleppa, M., Lipton, R. B., Rapoport, A. M., and Bigal, M. E., (2006). Mitochondrial dysfunction and migraine:evidence and hypotheses. Cephalalgia. 26:361–372.
112. Sperduto, R. D., Hu, T. S., and Milton, R. C., (1993). Hie Linxian cataract studies. Two nutrition intervention trials. Arch. Opthalmol. 111:1246–1253.
113. Srivastava, S. K., and Beutler, E., (1972). Galactose cataracts in riboflavin deficient rats. Biochem. Med. 6:372–379.
114. Srivastava, S. K., Villacorte, D., and Arya, D.V., (1973). Letter:distribution of glutathione reductase in lens epithelium, cortex and nucleus in various species and in human cataractous lenses. Exp. Eye Res. 16:319–521.
115. Stahmann, K. P., Revuelta, J. L., and Seulberger, H., (2000). Three biotechnical processes using Ashbya gossypii, Candida famata, or Bacillus subtilis compete with chemical riboflavin production. Appl. Microbiol. Biotechnol. 53:509–516.
116. Subramanian, V. S., Subramanya, S. B., Rapp, L., Marchant, J. S., Ma, T. Y., and Said, H. M., (2011). Differential expression of human riboflavin transporters-1, −2, and −3 in polarized epithelia:a key role for hRFT-2 in intestinal riboflavin uptake. Biochim. Biophys. Acta. 1808:3016–3021.
117. Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, N. S., Weinberger, A., Kuperman, Y., Harmelin, A., Kolodkin-Gal, I., Shapiro, H., Halpern, Z., Segal, E., and Elinav, E., (2014). Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 514:181–186.
118. Taniguchi, M., and Hara, T., (1983). Effects of riboflavin and selenium deficiencies on glutathione and its relating enzyme activities with respect to lipid peroxide content of rat livers. J. Nutr. Sci. Vitaminol. 29:283–292.
119. Thakur, K., and Tomar, S. K. De S., (2015). Lactic acid bacteria as a cell factory for riboflavin production. Microbial Biotechnol. doi:10.1111/1751-7915.12335.
120. Thakur, K., and Tomar, S. K., (2015a). Exploring indigenous Lactobacillus species from diverse niches for riboflavin production. J. Young Pharmacists. 7:122–127.
121. Thakur, K., and Tomar, S. K., (2015b). Invitro study of Riboflavin producing lactobacilli as potential probiotic. LWT-Food Sci. Technol. doi:10.1016/j.lwt.2015.12.059.
122. Tsao, S. M., Yin, M. C., and Liu, W. H., (2007). Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Nutr. Cancer. 59:8–13.
123. Valle, J. D. M., Lainoa, J. E. G., Savoy, D. G. G., and LeBlanc, J. G., (2014). Riboflavin producing lactic acid bacteria as a biotechnological strategy to obtain bio-enriched soymilk. Food Res. Int. 62:1015–1019.
124. Vitreschak, A. G., Rodionov, D. A., Mironov, A. A., and Gelfand, M. S., (2002). Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucl. Acids Res. 30:3141–3151.
125. Wang, G., Li, W., Lu, X., et al. (2011) Riboflavin alleviates cardiac failure in type1 diabetic cardiomyopathy. Heart Int. 6:21.
126. Webster, R. P., Gawde, M. D., and Bhattacharya, R. K., (1996). Modulation of carcinogen induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Lett. 98:129–135.
127. Webster, R. P., Gawde, M. D., and Bhattacharya, R. K., (1996). Modulation of carcinogen- induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Lett. 98:129–135.
128. Werbach, M. R., and Moss, J., (1999). Textbook of Nutritional Medicine. p. 246, Tliird Line Press, Inc, Tarzana, CA.
129. Williams, E. A., Powers, H. J., and Rumsey, R. D., (1995). Morphological changes in the rat small intestine in response to riboflavin depletion. Br. J. Nutr. 73:141–146.
130. Williams, E. A., Rumsey, R. D., and Powers, H. J., (1996). Cytokinetic and structural responses of the rat small intestine to riboflavin depletion. Br. J. Nutr. 75:315–324.
131. Wrong, O. M., Edmonds, C. J., and Chadwick, V. S., (1981). The Large Intestine:it's Role in Mammalian Nutrition and Homeostasis, Wiley and Sons, New York.
132. Yamada, K., Chen, Z., Rozen, R., and Matthews, R. G., (2001). Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc. Natl. Acad. Sci. USA 98:14853–58.
133. Yao, Y., Yonezawa, A., Yoshimatsu, H., Masuda, S., Katsura, T., and Inui, K., (2010). Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J. Nutr. 140:1220–1226.
134. Yates, C. A., Evans, G. S., Pearson, T., and Powers, H. J., (2003). Absence of luminal riboflavin disturbs early postnatal development of the gastrointestinal tract. Dig. Dis. Sci. 48:1159–1164.
135. Yates, C. A., Evans, G. S., and Powers, H. J., (2001). Riboflavin deficiency:early effects on post-weaning development of the duodenum in rats. Br. J. Nutr. 86:593–599.
136. Yonezawa, A., and Inui, K. I., (2013). Novel riboflavin transporter family RFVT/SLC52:Identification, nomenclature, functional characterization and genetic disease. Mol. Aspects Med. 34:693–701.